25. L. Chengsheng, L. Chenguang, and H.D. Kashappa, "Enhancement of Dissolution Rate of Valdecoxib Using Solid Dispersions
with Polyethylene Glycol 4000," Drug Dev. Ind. Pharm.
31 (1), 1–10 (2005).
26. A.R. Hedges. "Industrial Applications of Cyclodextrins," Chemical Reviews 98 (5), 2035–2044 (1998).
27. T. Pralhad and K. Rajendrakumar, "Study of Freeze-Dried Quercetincyclodextrin Binary Systems by DSC, FT-IR, X-ray Diffraction
and SEM Analysis," J. Pharm. Biomed. Anal. 34 (2), 333–339 (2004).
28. R.O. Williams, V. Mahaguna, and M. Sriwongjanya, "Characterization of an Inclusion Complex of Cholesterol and Hydroxypropyl-bcyclodextrin,"
Eur. J. Pharm. Biopharm. 46 (3), 355–360 (1998).
29. R.K. McMullan et al., "Topography of Cyclodextrin Inclusion Complexes: Part I. Classification of Crystallographic Data of α-Cyclodextrin Inclusion
Complexes,"Carbohydr. Res. 31 (1), 37–46 (1973).
30. D. Horter and J. B. Dressman, "Influence of Physiochemical Properties on Dissolution of Drugs in the Gastrointestinal
Tract," Advanced Drug Delivery Reviews 25 (1), 3–14 (1997).
31. J. P. Skelly et al., "Scale Up of Immediate Release Oral Solid Dosage Forms," J. Parenter. Sci. Technol. 47 (2), 52–56 (1993).
32. E. Galia, J. Horton, and J.B. Dressman, "Albendazole Generics—A Comparative In Vitro Study," Pharm. Res. 16 (12), 1871–1875 (1999).
33. C. Noory et al., "Rethinking the Use of Water as a Dissolution Medium," Dissolution Technol. 6 (4), 6–7 (1999).
34. V. P. Shah et al., "In Vitro Dissolution of Sparingly Water-Soluble Drug Dosage Forms," Int. J. of Pharm. 125 (11), 99–106 (1995).
35. M. Barzegar-Jalali et al., "Enhancement of Dissolution Rate and Anti-Inflammatory Effects of Piroxicam Using Solvent Deposition Technique," Drug Dev. Ind. Pharm. 28 (6), 681–686 (2002).
36. L. Tang, S.U. Khan, and N.A. Muhmmad, "Evaluation and Selection of Bio-relevant Dissolution Media for a Poorly Water Soluble
New Chemical Entity," Pharm. Develop. Technol. 6 (44), 531–540 (2001).
37. H. Vromans, A.C. Eisson, and F.L. Coenraad, "Mechanism of Dissolution of Drug-Cyclodextrin Complexes," Drug Dev. Ind. Pharm. 15, 250–255 (1989).
38. M.E. Aulton, "Pharmaceutical Technology," in: Pharmaceutics: The Science of Dosage Form Design (London, UK: Churchill Livingstone, 1988), pp. 600–616.
|
